Molecular classification and its clinical relevance in diffuse large B-cell lymphoma

DOI Web Site PubMed

Bibliographic Information

Other Title
  • DLBCLの遺伝子異常に基づく分類と層別化治療の可能性
  • DLBCL ノ イデンシ イジョウ ニ モトズク ブンルイ ト ソウ ベツカ チリョウ ノ カノウセイ

Search this article

Description

<p>Hematopoietic tumors represent a range of clinically and biologically diverse diseases, and within this, the lymphoid malignancies, especially B-cell lymphomas, are classified into many entities in the WHO classification system. It is thought that various molecular genetic abnormalities are involved in the tumorigenesis of diffuse large B-cell lymphoma (DLBCL). Due to recent developments in genetic analysis technology, novel and recurrent genetic abnormalities have been discovered. This is important knowledge for the development of new therapeutic drugs and may support indications for clinical trials, ultimately leading to the availability of more targeted therapies and precision medicine in the DLBCL arena. Here the possibility of patient stratification, based on genetic abnormality, has been described.</p>

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 60 (9), 1186-1192, 2019

    The Japanese Society of Hematology

Keywords

Details 詳細情報について

Report a problem

Back to top